TNDM
Tandem Diabetes Care Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
Market Cap: 1.78 Billion
Primary Exchange: NASDAQ
Website: https://www.tandemdiabetes.com/
Shares Outstanding: 65.6 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.1536021568458585
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Ethical Flags
Longest drawdown: 2227 trading days
From: 2014-01-10 To: 2024-03-07
Lowest Point:
Tandem Diabetes: ADA Presentations Reaffirm Control-IQ Excellent Performance
via: SeekingAlpha at 2019-06-11 03:46:36:000
Data presented by two studies, one NIH funded and one performed in France, supported the safety and efficacy of the Tandem ( TNDM ) t:slim X2 with Control-IQ. In a 6 month study in adults, when compared with sensor-augmented pump therapy, Control-IQ demonstrated better time in target range, … read more...
Tandem Diabetes: ADA Presentations Reaffirm Control-IQ Excellent Performance
via: SeekingAlpha at 2019-06-11 03:46:36:000
Data presented by two studies, one NIH funded and one performed in France, supported the safety and efficacy of the Tandem ( TNDM ) t:slim X2 with Control-IQ. In a 6 month study in adults, when compared with sensor-augmented pump therapy, Control-IQ demonstrated better time in target range, … read more...
Tandem Diabetes: ADA Presentations Reaffirm Control-IQ Excellent Performance
via: SeekingAlpha at 2019-06-11 03:46:36:000
Data presented by two studies, one NIH funded and one performed in France, supported the safety and efficacy of the Tandem ( TNDM ) t:slim X2 with Control-IQ. In a 6 month study in adults, when compared with sensor-augmented pump therapy, Control-IQ demonstrated better time in target range, … read more...
Insulet's closed-loop insulin pump shows positive effect in T1D study; shares up 2%
via: SeekingAlpha at 2019-06-10 09:22:08:000
Insulet ( PODD +2.3% ) is up on below-average volume on the heels of positive results from a study evaluating Omnipod Horizon, its hybrid closed-loop system, for glycemic control in children as young as two old with type 1 diabetes (T1D). The data were presented at the American Diabetes … read more...
Tandem Diabetes down 6% on despite positive insulin pump data
via: SeekingAlpha at 2019-06-10 07:19:41:000
Tandem Diabetes Care ( TNDM -6.3% ) slumps on almost 40% higher volume following its announcement of results from two studies of its t:slim X2 insulin pump with software called Control-IQ which automatically adjusts insulin delivery based on continuous glucose measurements (closed loop m… read more...
Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
via: Business Wire at 2019-06-09 14:30:00:000
Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2 insulin pump with Con… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-10-10 | 10.0 | 1.0 | 10.0 |